Reuters logo
BRIEF-Editas Medicine entered license agreement with broad institute for patent rights on Dec. 16
December 21, 2016 / 1:14 PM / a year ago

BRIEF-Editas Medicine entered license agreement with broad institute for patent rights on Dec. 16

Dec 21 (Reuters) - Editas Medicine Inc :

* Editas Medicine-after license agreement, broad institute granted co exclusive, worldwide, royalty-bearing, sublicensable license to cpf1 patent rights

* Editas Medicine - Dec 16, co entered license agreement with broad institute for patent rights related primarily to cpf1 compositions of matter Source text (bit.ly/2hUAptx) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below